Role of Echinacea in the management and prevention of acute respiratory tract infections in children: A systematic review of the evidence.
- 2025-10
- Review
- Journal of family & community medicine 32(4)
- Ahlam Mazi
- Reem M Alqahtani
- PubMed: 41234257
- DOI: 10.4103/jfcm.jfcm_144_25
- Low evidence
- Children
Evidence suggests that Echinacea purpurea, especially at higher doses (e.g., 2000 mg/day), may reduce RTI incidence, viral load, and symptom severity.
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 2000 mg/day